<VariationArchive VariationID="1803866" VariationName="NM_000384.3(APOB):c.6673dup (p.Thr2225fs)" VariationType="Duplication" Accession="VCV001803866" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-06" DateCreated="2022-12-17" MostRecentSubmission="2022-12-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1860891" VariationID="1803866">
      <GeneList>
        <Gene Symbol="APOB" FullName="apolipoprotein B" GeneID="338" HGNC_ID="HGNC:603" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_025791767.1" start="52097" stop="94741" display_start="52097" display_stop="94741" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="21001429" stop="21044073" display_start="21001429" display_stop="21044073" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="21224300" stop="21266944" display_start="21224300" display_stop="21266944" Strand="-" />
          </Location>
          <OMIM>107730</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APOB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APOB">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000384.3(APOB):c.6673dup (p.Thr2225fs)</Name>
      <CanonicalSPDI>NC_000002.12:21010194:TTTTT:TTTTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2p24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="21010194" stop="21010195" display_start="21010194" display_stop="21010195" variantLength="1" positionVCF="21010194" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="21233066" stop="21233067" display_start="21233066" display_stop="21233067" variantLength="1" positionVCF="21233066" referenceAlleleVCF="G" alternateAlleleVCF="GT" />
      </Location>
      <ProteinChange>T2225fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.21233071dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.21233071dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.21010199dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.21010199dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011793.2" sequenceAccession="NG_011793" sequenceVersion="2" change="g.38878dup">
            <Expression>NG_011793.2:g.38878dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000384.3" sequenceAccession="NM_000384" sequenceVersion="3" change="c.6673dup" MANESelect="true">
            <Expression>NM_000384.3:c.6673dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000375.3" sequenceAccession="NP_000375" sequenceVersion="3" change="p.Thr2225fs">
            <Expression>NP_000375.3:p.Thr2225fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000384.3(APOB):c.6673dup (p.Thr2225fs) AND multiple conditions" Accession="RCV002468491" Version="1">
        <ClassifiedConditionList TraitSetID="19838">
          <ClassifiedCondition DB="MedGen" ID="C4551990">Familial hypobetalipoproteinemia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1704417">Hypercholesterolemia, autosomal dominant, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-10-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-17" MostRecentSubmission="2022-12-17">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="19838" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18459" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hypobetalipoproteinemia, normotriglyceridemic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acanthocytosis with hypobetalipoproteinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial hypobetalipoproteinemia 1</ElementValue>
                <XRef ID="MONDO:0014252" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FHBL1</ElementValue>
                <XRef Type="MIM" ID="615558" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHBL</ElementValue>
                <XRef Type="MIM" ID="615558" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2876" />
                <XRef ID="2876" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with biallelic APOB-related familial hypobetalipoproteinemia (APOB-FHBL) may present from infancy through to adulthood with a range of clinical symptoms including deficiency of fat-soluble vitamins and gastrointestinal and neurologic dysfunction. Affected individuals typically have plasma total cholesterol, LDL cholesterol, and apo B levels below the fifth centile for age and sex. Acanthocytosis, elevated liver enzymes, and hyperbilirubinemia may also be found. The most common clinical findings are hepatomegaly, steatorrhea, and failure to thrive / growth deficiency. In the absence of treatment, affected individuals can develop atypical pigmentation of the retina; progressive loss of deep tendon reflexes, vibratory sense, and proprioception; muscle pain or weakness; dysarthria; ataxia; tremors; and steatohepatitis, fibrosis, and rarely, cirrhosis of the liver. Individuals with a heterozygous, typically truncating pathogenic variant in APOB are usually asymptomatic with mild liver dysfunction and hepatic steatosis. However, about 5%-10% of individuals with heterozygous APOB-FHBL develop relatively more severe nonalcoholic steatohepatitis requiring medical attention and occasionally progressing to cirrhosis, albeit very rarely.</Attribute>
                <XRef ID="NBK570370" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33983694</ID>
                <ID Source="BookShelf">NBK570370</ID>
              </Citation>
              <XRef ID="C4551990" DB="MedGen" />
              <XRef ID="MONDO:0014252" DB="MONDO" />
              <XRef Type="MIM" ID="615558" DB="OMIM" />
            </Trait>
            <Trait ID="1725" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial Hypercholesterolemia Type B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypercholesterolemia, autosomal dominant, type B</ElementValue>
                <XRef ID="MONDO:0007751" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">APOLIPOPROTEIN B-100, FAMILIAL DEFECTIVE</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">APOLIPOPROTEIN B-100, FAMILIAL LIGAND-DEFECTIVE</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIA, FAMILIAL, DUE TO LIGAND-DEFECTIVE APOLIPOPROTEIN B</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia Type IIb</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypercholesterolemia 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FHCL2</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8588" />
                <XRef ID="8588" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">APOB-Related Familial Hypercholesterolemia, Autosomal Dominant</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Familial hypercholesterolemia (FH) is characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. Individuals with a more severe phenotype, often as a result of biallelic variants, can present with very significant elevations in LDL-C (&gt;500 mg/dL), early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcific aortic valve disease.</Attribute>
                <XRef ID="NBK174884" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24404629</ID>
                <ID Source="BookShelf">NBK174884</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia – Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <XRef ID="C1704417" DB="MedGen" />
              <XRef ID="MONDO:0007751" DB="MONDO" />
              <XRef Type="MIM" ID="144010" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5407561" SubmissionDate="2022-12-05" DateLastUpdated="2022-12-17" DateCreated="2022-12-17">
        <ClinVarSubmissionID localKey="NM_000384.2:c.6673dup" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002764394" DateUpdated="2022-12-17" DateCreated="2022-12-17" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.6673dup p.(Thr2225AsnfsTer4) variant identified in the APOB gene has not previously been reported in the literature or public variant repositories (ClinVar and LOVD), and is absent from population databases (gnomAD v2.1.1 and v3.1.1, TOPMed Freeze 5) suggesting it is not a common benign variant in the populations represented in those databases. The c.6673dup variant is located in exon 26 of this 29-exon gene, predicted to incorporate a premature termination codon at position 2229 of the new reading frame, and result in either haploinsufficiency via nonsense mediated decay or loss of more than 50% of the wild-type protein if translated. There are multiple downstream truncating variants reported in ClinVar or literature in affected individuals with Hypobetalipoproteinemia. Based on the available evidence this c.6673dup variant is classified here as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/hhfhf6ms/nygc_assertion_criteria_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001397" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0003077" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000384.2:c.6673dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="144010" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615558" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12333914</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5407561" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001397" MappingRef="HP">
        <MedGen CUI="C2711227" Name="Hepatic steatosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5407561" TraitType="Disease" MappingType="XRef" MappingValue="615558" MappingRef="OMIM">
        <MedGen CUI="C4551990" Name="Familial hypobetalipoproteinemia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5407561" TraitType="Disease" MappingType="XRef" MappingValue="144010" MappingRef="OMIM">
        <MedGen CUI="C1704417" Name="Hypercholesterolemia, autosomal dominant, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5407561" TraitType="Finding" MappingType="XRef" MappingValue="HP:0003077" MappingRef="HP">
        <MedGen CUI="C0020473" Name="Hyperlipidemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

